In news that will no doubt be of concern for royal fans, King Charles was recently admitted to hospital after experiencing temporary side effects from his ongoing cancer treatment.
Buckingham Palace shared the health update, revealing that the King has cancelled a planned trip to Birmingham on Friday, March 28 to recover.
“Following scheduled and ongoing medical treatment for cancer this morning, the King experienced temporary side effects that required a short period of observation in hospital,” Buckingham Palace said in a statement.
“His Majesty’s afternoon engagements were therefore postponed.”
Fortunately, the King “has now returned to Clarence House” following his short hospital stay but “as a precautionary measure” his diary will be rescheduled.
The Palace emphasised that the King was deeply apologetic for any inconvenience caused.
“His Majesty would like to send his apologies to all those who may be inconvenienced or disappointed as a result,” they said.
A palace source confirmed to the BBC that the King’s hospitalisation was a “minor bump in a road that is very much heading in the right direction”.
The public first learnt of the King’s health concerns in early 2024 when he was hospitalised for a procedure related to benign prostate enlargement. Following further tests, doctors discovered the presence of cancer, prompting King Charles to begin a course of regular treatment to manage the condition.
Though the diagnosis was understandably a significant concern, the King’s determination to return to public duties soon after beginning treatment was reassuring. However, in accordance with medical advice, the number of public engagements has been limited to ensure he maintains his health.
While the Monarch’s treatment is said to be progressing positively, the Palace recently confirmed that King Charles will continue his therapy into 2025.
“His treatment has been moving in a positive direction and as a managed condition the treatment cycle will continue into next year,” a palace source revealed in 2024.
– with Reuters and PA.